{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:00:05Z","timestamp":1787241605857,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":196,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Peter Grant Hay Fund Fellowship"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.brachy.2012.03.004","type":"journal-article","created":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T17:46:23Z","timestamp":1336153583000},"page":"50-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Urethral strictures following high-dose-rate brachytherapy for prostate cancer: Analysis of risk factors"],"prefix":"10.1016","volume":"12","author":[{"given":"Benjamin R.","family":"Hindson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy L.","family":"Millar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwyn","family":"Matheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2012.03.004_bib1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0360-3016(02)02829-8","article-title":"Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial","volume":"53","author":"Pollack","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.03.004_bib2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0360-3016(98)00091-1","article-title":"Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer","volume":"41","author":"Zelefsky","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.03.004_bib3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2012.03.004_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0360-3016(00)00700-8","article-title":"Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial","volume":"48","author":"Storey","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.03.004_bib5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0360-3016(00)01414-0","article-title":"Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms","volume":"49","author":"Jackson","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.03.004_bib6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2007.04.011","article-title":"High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: Initial results of a randomised phase three trial","volume":"84","author":"Hoskin","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2012.03.004_bib7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ijrobp.2008.05.003","article-title":"An eight-year experience of HDR brachytherapy boost for localized prostate cancer: Biopsy and PSA outcome","volume":"73","author":"Bachand","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.03.004_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brachy.2009.04.007","article-title":"High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer","volume":"9","author":"Zwahlen","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2012.03.004_bib9","series-title":"Common Terminology Criteria for Adverse Events (CTCAE)","author":"Anonymous","year":"2010"},{"key":"10.1016\/j.brachy.2012.03.004_bib10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.juro.2007.03.126","article-title":"Incidence of urethral stricture after primary treatment for prostate cancer: Data From CaPSURE","volume":"178","author":"Elliott","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2012.03.004_bib11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijrobp.2010.10.009","article-title":"Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer","volume":"82","author":"Mohammed","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.03.004_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijrobp.2008.11.006","volume":"75","author":"Ishiyama","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.03.004_bib13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.radonc.2008.11.013","article-title":"Urethral stricture following high dose rate brachytherapy for prostate cancer","volume":"91","author":"Sullivan","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2012.03.004_bib14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/01.ju.0000113260.07979.d3","article-title":"Late urinary morbidity with high dose prostate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer","volume":"171","author":"Pellizzon","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2012.03.004_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.clon.2004.12.005","article-title":"The emerging role of high-dose-rate brachytherapy for prostate cancer","volume":"17","author":"Morton","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.brachy.2012.03.004_bib16","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ijrobp.2008.12.051","article-title":"Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer","volume":"75","author":"Konishi","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.03.004_bib17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brachy.2005.03.005","article-title":"Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer","volume":"4","author":"Hsu","year":"2005","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2012.03.004_bib18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ijrobp.2009.08.048","article-title":"Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: Preliminary results of RTOG 0321","volume":"78","author":"Hsu","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.03.004_bib19","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/01.ju.0000113299.34404.22","article-title":"High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds","volume":"171","author":"Grills","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2012.03.004_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.juro.2006.08.109","article-title":"High dose rate brachytherapy as a boost for the treatment of localized prostate cancer","volume":"177","author":"Phan","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2012.03.004_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/PL00002344","article-title":"3D interstitial HDR brachytherapy combined with 3D external beam radiotherapy and androgen deprivation for prostate cancer. Preliminary results","volume":"176","author":"Martin","year":"2000","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2012.03.004_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2004.10.014","article-title":"Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer","volume":"74","author":"Astrom","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2012.03.004_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.eururo.2004.11.014","article-title":"High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer","volume":"47","author":"Deger","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2012.03.004_bib24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0302-2838(02)00016-7","article-title":"High dose rate brachytherapy of localized prostate cancer","volume":"41","author":"Deger","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2012.03.004_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0360-3016(01)01758-8","article-title":"Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer","volume":"52","author":"Galalae","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.03.004_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0360-3016(01)01811-9","article-title":"The dosimetry of prostate brachytherapy-induced urethral strictures","volume":"52","author":"Merrick","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472112001110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472112001110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:06:15Z","timestamp":1761530775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472112001110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1538472112001110"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2012.03.004","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urethral strictures following high-dose-rate brachytherapy for prostate cancer: Analysis of risk factors","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2012.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Brachytherapy Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}